Incyte president Cagnoni sells $297,779 in common stock
Pablo J. Cagnoni, Incyte Corp's President and Global Head of R&D, sold 2,642 shares of the company's common stock, totaling $297,779, on October 15, 2026. At a price of $112.71 per share, Cagnoni disposed of his stock while simultaneously acquiring an equal number of shares through the exercise of employee stock options, valued at $173,741.
After these transactions, he personally holds 183,200 shares of Incyte common stock, including issuable restricted stock units and unvested performance stock units. The insider sale occurred as Incyte shares traded at $113.25, deemed undervalued by InvestingPro's Fair Value analysis. Incyte's P/E ratio of 14.49, according to InvestingPro data, is attractive relative to its near-term earnings growth potential.
Recent updates include H.C. Wainwright's Buy rating and $152 price target, UBS's Neutral rating with a $127 price target, and Stifel's Buy rating with a $157 target. These developments highlight ongoing interest and analysis from investment firms regarding Incyte's prospects.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
